Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis.

Frontiers in oncology·2021
Same author

The microbiological profile of patients with Fournier's gangrene: A retrospective multi-institutional cohort study.

Urologia·2021
Same author

Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.

Urologia internationalis·2021
Same author

Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263].

European urology oncology·2021
Same author

Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy.

Frontiers in endocrinology·2021

Related Experiment Video

Updated: Nov 11, 2025

Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

51.7K

Single-Port robot assisted partial nephrectomy: initial experience and technique with the da Vinci Single-Port

Simone Francavilla1,2,3, Michael R Abern4, Ryan W Dobbs4

  • 1Department of Urology, College of Medicine, University of Illinois, Chicago, IL, USA - simone.francavilla89@gmail.com.

Minerva Urology and Nephrology
|March 26, 2021
PubMed
Summary

Robotic-assisted partial nephrectomy using the da Vinci Single-Port (SP) platform is safe and feasible for experienced surgeons. This approach demonstrated satisfactory outcomes in operative time, ischemia, margins, and patient recovery for localized renal cancer.

More Related Videos

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.8K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K

Related Experiment Videos

Last Updated: Nov 11, 2025

Single Port Donor Nephrectomy
07:17

Single Port Donor Nephrectomy

Published on: March 12, 2011

51.7K
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.8K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Robotic-assisted partial nephrectomy (RAPN) is a key procedure for localized renal tumors.
  • Evaluating novel platforms like the da Vinci Single-Port (SP) is crucial for advancing surgical techniques.

Purpose of the Study:

  • To assess the safety and feasibility of RAPN utilizing the da Vinci SP platform.
  • To evaluate perioperative outcomes of SP RAPN in patients with renal cancer.

Main Methods:

  • A retrospective review of 14 patients undergoing SP RAPN for localized renal cancer.
  • Procedures were performed by experienced robotic surgeons using a transperitoneal approach with a single 2.5 cm incision.

Main Results:

  • No conversions to open or additional laparoscopic ports were required.
  • Trifecta outcome achieved in 79% of patients; median operative time 202 minutes, warm ischemia 20 minutes.
  • Low complication rates (2/14 required angioembolization), short hospital stay (1 day), and no disease recurrence at median 5-month follow-up.

Conclusions:

  • SP RAPN is a safe and feasible approach for single-site partial nephrectomy in experienced hands.
  • Satisfactory perioperative outcomes were observed for operative time, ischemia, margins, hospital stay, and pain.
  • The da Vinci SP platform represents a viable option for RAPN, offering promising results in this initial cohort.